J Biol Chem, Vol. 274, Issue 36, 25403-25410, September 3, 1999
Asymmetric Contributions to RNA Binding by the Thr45
Residues of the MS2 Coat Protein Dimer*
David S.
Peabody
and
Artemis
Chakerian
From the Department of Molecular Genetics and Microbiology,
University of New Mexico School of Medicine,
Albuquerque, New Mexico 87131
 |
ABSTRACT |
A prominent feature of the interaction of MS2
coat protein with RNA is the quasi-symmetric insertion of a bulged
adenine (A
10) and a loop adenine (A
4) into conserved pockets on
each subunit of the coat protein dimer. Because of its presence in both
of these adenine-binding pockets, Thr45 is thought to
play an important role in interaction with RNA on both subunits of the
dimer. To test the significance of Thr45, we introduced all
19 amino acid substitutions. However, we were initially unable to
determine the effects of the mutations on RNA binding because every
substitution compromised the ability of coat protein to fold correctly.
Genetic fusion of coat protein subunits reverted these protein
structural defects, allowing us to show that the RNA binding activity
of coat protein tolerates substitution of Thr45, but only
on one or the other subunit of the dimer. Single-chain heterodimer
complementation experiments suggest that the primary site of
Thr45 interaction with RNA is with A
4 in the
translational operator. Either contact of Thr45 with A
10
makes little contribution to stability of the RNA-protein complex, or
the effects of Thr45 substitution are offset by
conformational adjustments that introduce new, favorable contacts at
nearby sites.
 |
INTRODUCTION |
The coat protein of bacteriophage MS2 is a symmetric dimer that
serves both as the major structural protein of the virus particle and
as a repressor of viral replicase translation. Structural analyses of
coat protein (1-3) and of its RNA target (4), together with detailed
genetic and biochemical dissection of its RNA binding function (5-10),
have made this one of the best understood examples of RNA binding by a
protein. The structure of the binding site for coat protein is shown in
Fig. 1A. In the RNA-protein complex, the bulged A at
position
10 and the loop A at
4 project outward from the body of
the RNA, with the planes of the two bases aligned roughly parallel to
the helix axis. A
4 and A
10 form quasi-symmetric contacts with coat
protein, inserting themselves into pockets comprised of
Val29, Thr45, Ser47, and
Lys61 on different subunits of the dimer. Because operator
RNA is asymmetric, so too is the RNA-protein complex and we may
distinguish the two subunits of the dimer. Here we use the convention
of Valegard (11, 12), calling the the two subunits A and B. Inspection of the crystal structure of the RNA-protein complex suggests that ThrA45 makes H-bonds with N6 and N7 of A
4, while on the
other subunit ThrB45 seems to H-bond with N1 and N6 of
A
10. However, it is difficult to predict reliably the separate
contributions of these individual interactions to binding energy on
structural grounds alone.
We previously mapped genetically the MS2 RNA-binding site by isolating
a series of repressor-defective mutants in which the ability to bind
operator RNA was reduced (7). These mutants were isolated using a
two-plasmid genetic system in which coat protein expressed from one
plasmid represses translation of a replicase-
-galactosidase fusion
expressed from a second plasmid. Repressor-defective mutants make blue
colonies on plates containing the chromogenic
-galactosidase
substrate 5-bromo-4-chloro-3-indolyl-
-D-galactoside (X-gal).1 To ensure that
these mutational defects were confined to the RNA-binding site, each
mutant was screened for the ability to assemble into a virus-like
particle. This allowed us to discard mutants having gross perturbations
of protein structure. In this manner, we identified 10 different amino
acids, each residing on the surface of the coat protein
-sheet,
whose substitution specifically disrupted RNA binding activity (Fig.
1B). Given the apparent
importance of Thr45 in RNA binding, however, we were
surprised by the absence of substitutions identifying Thr45
as a binding site residue. Here we describe the introduction of all 19 amino acid substitutions at position 45. Unexpectedly, every mutation
reduced the ability of coat protein to fold correctly, apparently
explaining our initial failure to find repressor-defective, assembly-competent Thr45 substitutions. At first, this
frustrated our efforts to determine the effects of the mutations on RNA
binding, but genetic fusion of coat protein subunits reverted these
structural defects and allowed investigation of the RNA-binding role of
Thr45.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
A, structure of the MS2 translational
operator. Note the adenosines at 4 and 10. B, a
schematic illustration of the RNA-binding site of MS2 coat protein as
defined by genetic analysis. Shaded circles
identify the positions of amino acids whose substitution results in the
repressor-defective phenotype. Because the coat protein dimer is
symmetric and its RNA ligand is asymmetric, this is actually a
composite picture of two overlapping binding sites. C, the
heterodimer complementation map of the binding site. Here
shaded circles represent a single asymmetric RNA
binding site. The basis of heterodimer complementation is explained
under "Results" and in Fig. 5.
|
|
 |
EXPERIMENTAL PROCEDURES |
Recombinant DNA--
The mutants described in this paper were
constructed by site-directed mutagenesis using the method of Kunkel
et al. (13) and are simple variants of pCT119 (6, 7). In all
cases the complete nucleotide sequences of the mutant genes were
determined. The single-chain dimer (i.e. subunit fusion)
constructs were produced by methods described earlier (8), and
incorporated the various mutations described in the text. Plasmids were
introduced into Escherichia coli strain CSH41F
(14) for coat protein expression.
Protein Characterization--
To determine the relative amounts
of coat protein accumulating in soluble form and as insoluble
aggregates, cells from overnight 1-ml cultures were pelleted by
centrifugation, resuspended in 0.25 ml of 100 mM NaCl, 0.1 mM MgSO4, 0.01 mM EDTA, 10 mM Tris-HCl, pH 7.5, and sonicated three times (on ice) for
a total of 30 s. Insoluble material was then pelleted by
centrifugation. Pellets were resuspended in 0.25 ml of the above
buffer. Five µl of each supernatant or pellet fraction were combined
with an equal volume of 2× SDS gel sample buffer, heated to 95 °C
for 3 min, and applied to a 17.5% polyacrylamide gel containing SDS
(15). The gel was electroblotted to Nytran (Schleicher & Schuell), and
coat protein was visualized with anti-MS2 serum and
125I-labeled protein A (16).
The capacities of individual proteins to assemble into virus-like
particles were assessed by agarose gel electrophoresis as follows.
Cells from 1-ml overnight cultures were pelleted by centrifugation, resuspended in 0.25 ml of 100 mM NaCl, 0.1 mM
MgSO4, 0.01 mM EDTA, 50 mM
Tris-HCl, pH 7.5, and sonicated. After cellular debris was removed by
centrifugation, 10 µl from each lysate were applied to a 1.0%
agarose gel in 50 mM potassium phosphate, pH 7.0. Upon completion of electrophoresis, the gel was blotted to a Nytran membrane
(Schleicher & Schuell) and coat protein was visualized using anti-MS2
serum and 125I-protein A (NEN Life Science Products).
Measuring Translational Repression--
The RNA binding
activities of the coat protein variants were assessed by their
abilities to repress translation of a replicase-
-galactosidase fusion protein produced from pRZ5 in strain CSH41F
(see
Ref. 6 for details). Cells containing the appropriate plasmids were
streaked on LB plates containing X-gal and compared for relative
blueness. Assay of
-galactosidase was performed in triplicate by the
method described by Miller (14). Activities are reported as percentages
of the activity of an unrepressed control.
RNA Binding Assays--
Radioactive RNA was produced by the
method of Draper et al (17). Protein-excess nitrocellulose
filter-binding assays (18) were performed with [32P]RNA
at a concentration of 10 pM, which was titrated with coat proteins purified as described by Peabody (6). Binding curves were
fitted to a bimolecular equilibrium using the Kaleidagraph program from
Abelbeck Software. The concentration of active coat protein in each
preparation was determined in a similar filter-binding assay, but one
in which 50 nM protein solutions were titrated with
excess radioactive RNA.
 |
RESULTS |
Effects of Amino Acid Substitutions at Position 45 on the Structure
and Translational Repressor Function of Coat Protein--
Using
site-directed mutagenesis, codons for the 19 amino acid alternatives to
threonine were introduced at position 45 in the coat sequence in
plasmid pCT119. The effects of amino acid substitutions on RNA binding
were monitored by a translational repression assay in which functional
coat protein expressed from pCT119 represses the synthesis of a
replicase-
-galactosidase fusion protein expressed from pRZ5 (6).
Thus, the extent of repression is conveniently determined by comparing
the blueness of bacterial colonies on solid medium containing the
chromogenic substrate X-gal. Table I
lists the mutations and shows their effects on translational repression
as judged by colony color. The
-galactosidase activities of some
mutants were determined using
o-nitrophenyl-
-D-galactoside as substrate
(Table II). Every substitution resulted
in a translational repressor defect. Most mutants showed little or no
ability to repress translation. Even conservative substitutions showed
significant loss of repressor activity. For example, replacing
Thr45 with serine (T45S) resulted in a repressor
defect.
View this table:
[in this window]
[in a new window]
|
Table I
The translational repressor activities of wild-type (pCT119) and the
Thr45 mutants as indicated by colony color on X-gal plates
Plasmid pUCter3 produces no coat protein and serves as the no-repressor
control.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
The -galactosidase activities produced by selected mutants as
single-chain homodimers or as heterodimers with wild-type
These values are percentages of the enzyme activity produced in the
unrepressed case (pUCter3).
|
|
In order to conclude with confidence that an amino acid substitution
directly disrupts the RNA binding site, it is necessary to exclude the
alternative possibility that it grossly perturbs coat protein
structure, affecting RNA binding activity only secondarily. This is
readily accomplished by measuring the ability of coat protein to
assemble into virus-like particles, a property that depends on proper
protein folding and is easily monitored in an agarose gel
electrophoretic assay (7). Virus-like particles possess a distinctive
mobility and may be visualized with anti-MS2 serum and
125I-protein A after blotting to nitrocellulose. Fig.
2A shows that every amino acid
substitution at position 45 reduced the yield of virus-like particles.
All the mutants were significantly impaired in their abilities to
produce capsids; about half were apparently completely defective for
capsid synthesis. Since its location in the structure of coat protein
indicates no direct role for Thr45 in the assembly of coat
dimers into capsids, these results suggest that the mutant proteins
fail to fold normally into the dimers that serve both as translational
repressors and as the precursors to capsids.

View larger version (92K):
[in this window]
[in a new window]
|
Fig. 2.
A, agarose gel electrophoresis and
Western blot of capsids produced by the WT and various T45 mutants
(identified using the single-letter amino acid code).
B, SDS-polyacrylamide gel electrophoresis and Western blot
analysis of the coat proteins produced by WT and various T45 mutants
(again denoted by the single-letter amino acid code). Cells
were lysed by sonication and separated into soluble and insoluble
fractions by centrifugation. In each pair of lanes, the one on the
left is the soluble fraction, and the one on the
right is the insoluble fraction.
|
|
As an additional test of the ability of mutant proteins to acquire
native structure, we determined their intracellular fates. It is
commonly observed that mutant proteins which fail to fold correctly are
either degraded by proteolysis or accumulate as insoluble aggregates in
inclusion bodies. Sonicated cell lysates were fractionated by
centrifugation into soluble and insoluble fractions, which were then
subjected to SDS gel electrophoresis and Western blotting. Coat
proteins were visualized using anti-MS2 serum and
125I-protein A. Fig. 2B shows the results.
Wild-type coat protein was found mostly in the soluble fraction, and
this was also true of T45E, T45Q, T45K, and T45R. The remaining mutant
coat proteins suffered the following fates. (i) T45P, T45N, T45D, T45F,
T45G, T45H, and T45V showed little or no coat protein in either
fraction and were apparently proteolytically degraded. (ii) In other
cases (T45A, T45S, T45 M, T45Y, T45L, T45I, T45W, and
T45C) coat protein was detected, but half or more was found in the
insoluble fraction.
Genetic Fusion of Subunits of the Coat Protein Dimer Corrects the
Structural Defects--
We reported previously the construction of
p2CTdl-13, a plasmid in which the coat sequence is duplicated and the
two sequences are joined together in a translational fusion (8).
Because the N and C termini of different subunits are near each other in space, the single-chain "dimer" folds properly and possesses the
RNA binding and capsid assembly functions typical of wild-type coat
protein. This fused dimer possesses greatly increased resistance to
denaturation by urea and corrects the structural defects imposed by
certain peptide insertions (19) and temperature-sensitive mutations.2 Therefore, we
wondered whether the defects conferred by the Thr45
substitutions might also be reverted by subunit fusion. We created genetic subunit fusions using a selection of mutants: T45P, T45N, T45V,
T45A, T45S, T45L, and T45G. In addition to creating mutant homodimers,
which we call 2T45P, 2T45N, etc., many of the mutant sequences were
also paired with the wild-type in either the N- or C-terminal halves of
the duplicated molecule. We call these, for example, WT-T45P when the
mutant sequence is in the 3'-half of the fused dimer, and T45P-WT when
it is in the 5'-half.
Tests for capsid assembly activity (Fig.
3A) and for production of
soluble protein (Fig. 3B) showed that, with one exception, subunit fusion corrected the structural defects of these mutants. This
was true whether a mutant was paired with itself in a fused homodimer,
or with the wild-type sequence in either half of a fused heterodimer.
In their single-chain forms, they were generally produced in normal
amounts and in soluble form. They also assemble into virus-like
particles, although in a few cases, namely WT-T45V, 2T45V, T45G-WT, and
2T45G, assembly activity was only partially restored (Fig.
3B). Therefore, subunit fusion promotes the formation of
native coat protein structure. The one exception was T45P. Although
subunit fusion rescued it from proteolysis so that the fused dimer
derivatives (WT-T45P, T45P-WT, and 2T45P) were present in normal
amounts, they were found almost entirely in the aggregated fraction,
and no capsids were detected. The inability of subunit fusion to fully
correct the T45P defect is consistent with the difficulty of
incorporating prolines into
-sheets.

View larger version (85K):
[in this window]
[in a new window]
|
Fig. 3.
A, agarose gel electrophoresis and
Western blot analysis of capsids produced by the single-chain
constructs. B, SDS-polyacrylamide gel electrophoresis and
Western blot analysis of the soluble (the left lane in each pair) and aggregated (right lanes) coat proteins produced by the wild-type
(2CT) and mutant (single-letter amino acid code)
single-chain constructs.
|
|
The translational repressor activities of the proteins were assessed by
assays of
-galactosidase activity present in strains containing the
appropriate plasmids (Table II). In most cases, subunit fusion
apparently restored whatever degree of repressor activity had been lost
due to folding defects, allowing us to distinguish the
protein-structural and RNA-binding site effects of the amino acid
substitutions. Although many mutants were still repressor-defective,
others showed complete, or nearly complete, restoration of repressor
activity. The WT-T45S and T45S-WT and the WT-T45G and T45G-WT
heterodimer fusions repressed translation as well as wild-type, but
with the 2T45S and 2T45G homodimers repressor activity was restored
only incompletely. Three other mutants we tested (T45A, T45C, and T45N)
were nearly as good repressors as wild-type when paired with the
wild-type sequence in heterodimers, but, again, each was less active in
mutant homodimers.
We also determined the RNA binding activities of some of the fused
dimer variants in vitro by measuring their abilities to retain 32P-labeled MS2 operator RNA on nitrocellulose
filters. The results shown in Fig. 4
indicate that the WT homodimer and the WT-T45S heterodimer were
indistinguishable in their abilities to bind RNA, each giving
dissociation constants of 1 nM. The 2T45S homodimer and the
WT-T45G heterodimer each bound only a little less well than WT at
approximately 2 nM. WT-T45A and 2T45A, the worst binders of
the group, gave 3 and 4 nM dissociation constants
respectively. We also attempted to determine the binding affinity of
2T45G, but were unable to reconstitute its binding activity after the acid denaturation step used in its purification (6). We assume this to
be caused by a failure of this mutant to refold properly. The results
of in vitro binding analyses roughly parallel the in
vivo translational repression assays, although some of
recombinants (e.g. 2T45A) seem to bind RNA better than might
be expected from their relatively poor translational repressor
activities.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Nitrocellulose filter-binding assays of the
RNA binding activities of wild-type single-chain dimers and the
indicated single-chain heterodimers. Dissociation constants are
given within each panel.
|
|
Mapping the Site of Thr45 Interaction to A
4 or
A
10--
The crystal structure of the coat protein-RNA complex
suggests that the two Thr45 residues make contributions to
RNA binding by interacting with A
4 and A
10 on different subunits of
the dimer. However, the results described above indicate that one of
the Thr45 residues is largely dispensable. Which of the two
interactions is the important one? Structural analysis of the coat
protein-RNA complex seems inconclusive on this point. On subunit A
Thr45 is thought to make H-bonds with N6 and N7 of A
4,
and on subunit B it is reputed to form similar interactions with N1 and
N6 of A
10 (11, 12). However, it is not possible to predict reliably the contributions of these individual interactions to the energy of RNA
binding on structural grounds alone. We sought to resolve this question genetically.
In solution coat protein is a symmetric dimer and therefore contains
two binding sites for its asymmetric RNA ligand. Since the two sites
overlap, only one can be occupied at any instant, accounting for the
binding stoichiometry of one RNA per coat protein dimer. A bound RNA
molecule makes contacts with both subunits of the dimer, so it is
convenient to think of each binding site as being made up of two
non-identical half-sites, each representing the contribution of one
monomer to a complete binding site. We may label the half-sites of one
binding site A and B, and those of the other site A' and B' (Fig.
5A). In the conventional
homodimer, any amino acid substitution that inactivates a particular
half-site does so on both monomers, thereby inactivating both complete
binding sites (Fig. 5B). However, the ability to genetically
fuse the two subunits of coat protein makes it possible to create
single-chain heterodimers in which the two halves of the molecule may
contain different combinations of mutant and wild-type sequences. When a mutation inactivating one half-site, say A, is paired in a
heterodimer with a wild-type sequence, one intact, functional site is
restored (Fig. 5C). Likewise, when a mutation inactivating
one half-site (for example A) is paired with a mutation inactivating
the other half-site (B), one binding site is doubly defective, but one
functional site is produced (Fig. 5D). These heterodimers
are competent to bind RNA. Of course, the heterodimerization of mutants
with different lesions in the same half-site yields molecules
nonfunctional for RNA binding. On the other hand, mutations affecting
residues that play roles in both half-sites are not complementable by
any mutant or wild-type sequence (although if the affected amino acid
plays unequal roles in the two half-sites, they may be partially
complementing). This reasoning formed the basis for the heterodimer
complementation experiments that we used to create a functional map of
one asymmetric binding site on the surface of the symmetric coat
protein dimer (8). This map shows striking similarity to one derived
from x-ray crystallographic analysis of the coat protein-RNA complex and allows a fairly complete correlation of the results of structural and genetic analyses.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
Illustrations showing the effects on the
RNA-binding site of combining mutant and/or wild-type sequences in
single-chain coat protein heterodimers. Asterisks
indicate mutational inactivation of a half-site. A, a
wild-type homodimer. B, mutant homodimer in which mutation
has inactivated half-site A in the picture at left, or
half-site B in the picture on the right. C, a
wild-type-mutant heterodimer. D, a mutant heterodimer in
which the two monomers have mutations in different half-sites.
|
|
We wanted to determine whether Thr45 could be assigned by
this method to one of the half-sites. The crystal structure tells us
that A
4 and A
10 are bound on different subunits of the dimer and,
further, it identifies the genetically defined half-sites to which they
are bound (8). Therefore, pairing a Thr45 mutation with
ones previously assigned to one or the other half-site should make it
possible to determine whether the primary role of Thr45 is
in binding A
4 or A
10. From the experiments described above, we knew
that some Thr45 mutants could be complemented by the
wild-type sequence in single-chain heterodimers. We decided to create
heterodimer constructs in which T45A was paired with Y85H or N87S,
which were previously mapped to half-site A (the position of A
4
contact), and with N55D and T91I from half-site B (where A
10 is
bound). These mutants were chosen for the complementation studies
because their roles in RNA binding are fairly well defined by both
structural and genetic analyses. The ring of TyrA85 stacks
on U
5, and its hydroxyl group H-bonds to the phosphate of the same
nucleotide. The side chain amide of AsnA87 forms an H-bond
to O2 of U
5. AsnB55 interacts with the
phosphate of A
7. ThrB91 does not appear to contact RNA,
and its substitution in the T91I mutant apparently inactivates the
RNA-binding site by steric interference in half-site B. T45A was paired
with these mutants to produce the single-chain heterodimers listed in
Table III.
View this table:
[in this window]
[in a new window]
|
Table III
Complementation of T45A in heterodimers with wild-type N55D, Y85H,
N87S, or T91I
The numbers represent percentages of the -galactosidase activity
produced in the unrepressed state.
|
|
Agarose gel electrophoresis showed that each of the heterodimers was
competent for capsid assembly, indicating that all are properly folded
(results not shown). The RNA-binding activities of the various
heterodimers were tested by comparing their abilities to repress
-galactosidase synthesis in bacteria containing the plasmid pRZ5.
Table III compares the
-galactosidase activities of bacteria with
the indicated heterodimer constructs. T45A is capable of
efficient translational repression when paired in heterodimers with
N55D or T91I. It complements these mutants as well, or nearly as well,
as does a wild-type subunit. But when paired with Y85H or N87S, each of
the T45A-containing heterodimers is a poor repressor. This behavior
assigns Thr45 to half-site A where it interacts with
A
4.
 |
DISCUSSION |
Protein Structure Effects of Thr45
Substitutions--
Even before the determination of the structure of
the RNA-protein complex, an important role for Thr45 was
suggested by its conservation across an evolutionary spectrum of RNA
phage coat proteins. An involvement of Thr45 in RNA binding
was strongly indicated when the crystal structure of the RNA-protein
complex revealed the presence of quasi-symmetric interactions of the
bulged adenosine at
10 and the loop adenosine at
4 with a site
containing Val29, Thr45, Ser47, and
Lys61 and which is present in both halves of the dimer (11,
12). Therefore, we were surprised by our failure to find substitutions implicating Thr45 as a component of the binding site in our
collection of repressor-defective mutants. The results presented here
provide an explanation; the structure of coat protein is perturbed by
every substitution of residue 45, so that all but a few
Thr45 mutants would have been discarded during the screen
for capsid assembly. Moreover, those mutants that still produced a
significant amount of capsid must have been rare, if not absent, in our
mutant library, since only one of them (T45S) could have resulted from a single-nucleotide substitution.
Some other amino acids in the RNA-binding site apparently exhibit a
sensitivity to substitution similar to that of Thr45.
Recently, we introduced mutations at Val29,
Ser47, Thr59, and Lys61, residues
also implicated in A
4 and A
10 binding. Ser47 and
Thr59 seem to tolerate substitutions, but many different
changes at positions 29 and 47 destroyed the ability of the protein to
assemble into capsids.2
We find the extreme substitution sensitivity of Thr45 to be
surprising, but as our interest is mainly directed toward the
RNA-binding site, we have made little effort to characterize the
protein structural defects imparted by these mutations. However,
several previous studies have systematically examined the effects on
protein stability of amino acid changes on the surfaces of
-sheets.
They paint a complicated picture. Statistical analysis of amino acid
sequences long ago showed that the various amino acids have different
tendencies to appear in
-structure (20, 21), and some mutational
studies have suggested that the rank order of these statistically
defined propensities roughly correlates with the protein stability
effects of amino acid substitutions (22-24). Threonine is generally
near the top of such rankings (22, 23, 25). Effects of substitutions on
stability are observed even when pains are taken to eliminate interactions of the mutated amino acid with nearby side chains (22,
25), presumably reflecting the intrinsic tendency of an amino acid to
appear in a
-strand. However, structural context also plays an
important role; mutational analyses demonstrate that the rank order of
apparent
-sheet propensities can differ sharply from one protein to
another, and even depends on the precise location of an amino acid
within the sheet of a single protein (26). The importance of context is
also supported by skewing in the frequencies with which certain amino
acid pairs are found in neighboring positions on adjacent
-strands
(27, 28), and by the experimental determination of stability effects of
pairwise amino acid substitutions (24). Inspecting the local
environment of Thr45 shows that its non-H-bonded
cross-strand neighbor is Glu31. Hutchinson et
al. (28), in a statistical survey of favored residues in
-sheets, showed that Thr-Glu pairs are often found in such positions.
Effects on RNA Binding--
The crystal structure of the coat
protein-RNA complex suggests a key role for Thr45 on
both subunits of the coat dimer in stabilizing the
RNA-protein complex (11, 12). Specifically it was proposed that
ThrA45 H-bonds with N6 and N7 of A
4 and
ThrB45 with N1 and N6 of A
10. However, our finding that
several substitutions permit normal or near normal translational
repression when present in only one half of the dimer suggests that one
of the Thr45 residues makes little or no contribution to
the energy of RNA binding. Since structural studies implicate the
Thr45 hydroxyl group in RNA binding, it was no surprise
that serine was a reasonable replacement. In fact, the WT-T45S and
T45S-WT recombinants were fully active as translational repressors.
However, 2T45S, which contains the serine replacement in both halves of the dimer, did not quite attain wild-type activity, suggesting that the
methyl group of one of the threonines must play some role in
RNA-binding. This does not imply necessarily that the methyl group
participates in interaction with RNA directly. It may simply engage in
interactions that favor the correct positioning of the hydroxyl.
The complete, or nearly complete, recovery of translational repressor
activity by heterodimer constructs in which one wild-type subunit was
paired with T45G, T45N, T45C, or T45A adds weight to the argument that
the identity of Thr45 is really crucial to RNA binding on
only one of the two subunits. Moreover, the pattern of complementation
when the T45A mutant is combined with other RNA-binding site mutations
in single-chain heterodimers indicates that it is primarily
ThrA45's interaction with A
4 that is sensitive to substitution.
These results have at least three possible explanations. (i)
ThrB45 interactions with RNA might make only a small
contribution to the stability of the RNA-protein complex. Additional
support for this idea comes from studies of the effects of nucleotide
substitutions of A
10. Wu and Uhlenbeck (29) found that guanine,
inosine, and 2-aminopurine were acceptable replacements for the bulged nucleotide. Since these remove the amino group at position C-6 of
the base (2-aminopurine) or replace it with a keto group (guanosine or
inosine), it seems unlikely that crucial contacts are made at this
site. (ii) Some amino acid substitutions might replace lost contacts
with new ones. This seems an unlikely alternative. It makes some sense
that serine and cysteine should be tolerable replacements of
ThrB45, but, despite their rather large structural
differences, glycine works as well, and alanine and asparagine work
nearly as well as serine and cysteine when combined in heterodimers
with a wild-type sequence. (iii) Conformational adjustments may allow
the formation of new contacts, which compensate for the loss of H-bond
interactions that accompany ThrB45 substitution. This
possibility is supported by the x-ray structure of the complex of the
T45A mutant with RNA, which reveals RNA conformational changes in the
vicinity of both A
4 and A
10 (30). Some of these changes, especially
those near A
10, seem to offset partially the loss of normal
Thr45 contacts by forming additional favorable contacts at
other nearby sites. We wonder whether similar, but more extensive,
conformational adjustments accompany the substitution of
Thr45 with Gly, offsetting the loss of Thr45
side-chain contacts so completely that the WT-T45G heterodimer is as
good a repressor as wild-type.
The coat proteins of different RNA phages bind different hairpins (31).
However, they do not appear to have acquired the wide range of
specificities that characterizes, for example, the ribonucleoprotein
class of proteins (32), which also use a
-sheet as the RNA binding
site. Our results point out two constraints that must limit the ability
of RNA phage coat proteins to evolve new RNA binding specificities.
First, the stability of coat protein can be highly sensitive to
substitution of RNA-binding site amino acids. This limits its ability
to adapt to new ligands. Second, because of the two-fold symmetric
nature of the coat protein dimer, any change in one half of the
RNA-binding site is accompanied automatically by an identical change in
the other half. Therefore, it may be difficult for coat protein to
acquire new specificities for intrinsically asymmetric RNA ligands. One
wonders what new specificities could be conferred to single-chain coat
proteins, where the destabilizing effects of amino acid substitutions
are better tolerated, and where the RNA-binding site is free to develop asymmetries.
 |
FOOTNOTES |
*
This work was supported by a grant from the National
Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 505-272-0071;
Fax: 505-272-9494; E-mail: dpeabody@salud.unm.edu.
2
D. S. Peabody and A. Chakerian, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
X-gal, 5-bromo-4-chloro-3-indolyl-
-D-galactoside;
WT, wild-type.
 |
REFERENCES |
| 1.
|
Valegard, K.,
Liljas, L.,
Fridborg, K.,
and Unge, T.
(1990)
Nature
345,
36-41[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Golmohammadi, R.,
Valegard, K.,
Fridborg, K.,
and Liljas, L.
(1993)
J. Mol. Biol.
234,
620-639[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Ni, C.-Z,
Syed, R.,
Kodandapani, R.,
Wickersham, J.,
Peabody, D. S.,
and Ely, K. R.
(1995)
Structure
3,
255-263[Medline]
[Order article via Infotrieve]
|
| 4.
|
Borer, P. N.,
Lin, Y.,
Wang, S.,
Roggenbuck, M. W.,
Gott, J. M.,
Uhlenbeck, O. C.,
and Pelczer, I.
(1995)
Biochemistry
34,
6488-6503[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Romaniuk, P. J.,
Lowary, P.,
Wu, H.,
Stormo, G.,
and Uhlenbeck, O. C.
(1987)
Biochemistry
26,
1563-1568[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Peabody, D. S.
(1990)
J. Biol. Chem.
265,
5684-5689[Abstract/Free Full Text]
|
| 7.
|
Peabody, D. S.
(1993)
EMBO J.
12,
595-600[Medline]
[Order article via Infotrieve]
|
| 8.
|
Peabody, D. S.,
and Lim, F.
(1996)
Nucleic Acids Res.
24,
2352-2359[Abstract/Free Full Text]
|
| 9.
|
Lim, F.,
Spingola, M.,
and Peabody, D. S.
(1994)
J. Biol. Chem.
269,
9006-9010[Abstract/Free Full Text]
|
| 10.
|
Lim, F.,
Spingola, M.,
and Peabody, D. S.
(1996)
J. Biol. Chem.
271,
31839-31845[Abstract/Free Full Text]
|
| 11.
|
Valegard, K.,
Murray, J. B.,
Stockley, P. G.,
Stonehouse, N.,
and Liljas, L.
(1994)
Nature
371,
623-625[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Valegard, K.,
Murray, J. B.,
Stonehouse, N. J.,
van den Worm, S.,
Stockley, P. G.,
and Liljas, L.
(1997)
J. Mol. Biol.
270,
724-738[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Kunkel, T. A.,
Roberts, J. D.,
and Zakour, R. A.
(1987)
Methods Enzymol.
154,
367-382[Medline]
[Order article via Infotrieve]
|
| 14.
|
Miller, J. H.
(1972)
Experiments in Molecular Genetics
, pp. 352-355, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 15.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Burnette, W. N.
(1981)
Anal. Biochem.
112,
195-203[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Draper, D. E.,
White, S. A.,
and Kean, J. M.
(1988)
Methods Enzymol.
164,
221-237[Medline]
[Order article via Infotrieve]
|
| 18.
|
Carey, J.,
Cameron, V.,
de Haseth, P. L.,
and Uhlenbeck, O. C.
(1983)
Biochemistry
22,
2601-2610[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Peabody, D. S.
(1997)
Arch. Biochem. Biophys.
347,
85-92[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Chou, P. Y.,
and Fasman, G. D.
(1974)
Biochemistry
13,
211-222[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Chou, P. Y.,
and Fasman, G. D.
(1978)
Mol. Biol.
47,
45-148
|
| 22.
|
Minor, D. L.,
and Kim, P. S.
(1994)
Nature
367,
660-663[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Kim, C. A.,
and Berg, J. M.
(1993)
Nature
362,
267-270[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Smith, C. K.,
and Regan, L.
(1995)
Science
270,
980-982[Abstract/Free Full Text]
|
| 25.
|
Smith, C. K.,
Withka, J. M.,
and Regan, L.
(1994)
Biochemistry
33,
5510-5517[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Minor, D. L.,
and Kim, P. S.
(1994)
Nature
371,
264-267[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Lifson, S.,
and Sander, S.
(1980)
J. Mol. Biol.
139,
627-639[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Hutchinson, E. G.,
Sessions, R. B.,
Thornton, J. M.,
and Woolfson, D. N.
(1998)
Protein Sci.
7,
2287-2300[Abstract]
|
| 29.
|
Wu, H.-N.,
and Uhlenbeck, O. C.
(1987)
Biochemistry
26,
8221-8227[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
van den Worm, S. H. E.,
Stonehouse, N. J.,
Valegard, K.,
Murray, J. B.,
Walton, C.,
Fridborg, K.,
Stockley, P. G.,
and Liljas, L.
(1998)
Nucleic Acids Res.
26,
1345-1351[Abstract/Free Full Text]
|
| 31.
|
van Duin, J.
(1988)
in
The Bacteriophages
(Calendar, R., ed)
, pp. 117-161, Plenum Press, New York
|
| 32.
|
Kenan, D. J.,
Query, C. C.,
and Keene, J. D.
(1991)
Trends Biochem. Sci.
16,
214-220[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.